Expert Bio
Dr. Hector Carvallo, Senior Fellow, Endocrinology
Dr. Hector Carvallo, PhD, is a distinguished endocrinologist from Buenos Aires, Argentina, with a notable career in both academia and clinical practice. He is a retired professor from the University of Buenos Aires and the former director of one of the city’s largest hospitals. Dr. Carvallo has made significant contributions to the field of infectious diseases, particularly through his pioneering work in the first human trials of ivermectin for the prevention of COVID-19.
In addition to ivermectin, Dr. Carvallo has led investigations into the potential use of other repurposed drugs, such as bromhexine, dexamethasone, aspirin, enoxaparin, and carrageenan for COVID-19 treatment. His extensive research and clinical experience have resulted in numerous publications in peer-reviewed journals, and his work has been instrumental in successfully treating thousands of COVID patients.
Dr. Carvallo is widely recognized for his dedication to evidence-based medicine and his innovative approaches to tackling complex medical challenges. His leadership and expertise continue to influence the global medical community, particularly in the areas of endocrinology and infectious diseases.
